These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18752950)

  • 21. Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites.
    Karkhanis A; Lam HY; Venkatesan G; Koh SK; Chai CL; Zhou L; Hong Y; Kojodjojo P; Chan EC
    Biochem Pharmacol; 2016 May; 107():67-80. PubMed ID: 26972388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-arrhthmic effects of injectable amiodarone in resuscitation during cardiovascular surgery, 2 cases].
    Michat L; Cabrol C; Mattei MF; Gobin F; Bourel LM; Grandjbakhch I; Guiraudon G
    Nouv Presse Med; 1976 Sep; 5(31):1996. PubMed ID: 980718
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous amiodarone modifies autonomic balance and increases baroreflex sensitivity in conscious rats.
    Dias da Silva Valdo J; Viana Públio CC; de Melo Alves R; Fazan R; Ruscone TG; Porta A; Malliani A; Salgado HC; Montano N
    Auton Neurosci; 2002 Jan; 95(1-2):88-96. PubMed ID: 11871788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous amiodarone in intensive care. Time for a reappraisal?
    Hughes M; Binning A
    Intensive Care Med; 2000 Dec; 26(12):1730-9. PubMed ID: 11271079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dronedarone: NICE enough?
    Khoo CW; Lim HS; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1049-51. PubMed ID: 20670181
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical pharmacology of anti-arrhythmia agents].
    Zeng GY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Mar; 11(1):15-9. PubMed ID: 6884198
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry.
    Lagrutta A; Regan CP; Zeng H; Imredy JP; Koeplinger K; Morissette P; Liu L; Wollenberg G; Brynczka C; Lebrón J; DeGeorge J; Sannajust F
    Sci Rep; 2017 Mar; 7():44820. PubMed ID: 28327633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone-induced pulmonary toxicity: case study with syndrome analysis.
    Van Cott TE; Yehle KS; DeCrane SK; Thorlton JR
    Heart Lung; 2013; 42(4):262-6. PubMed ID: 23835168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone.
    Hershman JM; Nademanee K; Sugawara M; Pekary AE; Ross R; Singh BN; DiStefano JJ
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):193-9. PubMed ID: 3953231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of amiodarone in contemporary management of complex cardiac arrhythmias.
    Mujović N; Dobrev D; Marinković M; Russo V; Potpara TS
    Pharmacol Res; 2020 Jan; 151():104521. PubMed ID: 31756386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of interactions of anti-arrhythmia agents during their combined use].
    Adnan Abdalla ; Mazur NA; Shestakova NV
    Kardiologiia; 1991 Feb; 31(2):87-91. PubMed ID: 2041300
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.
    Chow MS
    Ann Pharmacother; 1996 Jun; 30(6):637-43. PubMed ID: 8792951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level.
    Bogazzi F; Bartalena L; Brogioni S; Burelli A; Raggi F; Ultimieri F; Cosci C; Vitale M; Fenzi G; Martino E
    Eur J Endocrinol; 2001 Jul; 145(1):59-64. PubMed ID: 11415853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology and toxicology of a new aqueous formulation of intravenous amiodarone (Amio-Aqueous) compared with Cordarone IV.
    Somberg JC; Cao W; Cvetanovic I; Ranade V; Molnar J
    Am J Ther; 2005; 12(1):9-16. PubMed ID: 15662287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class III drugs: amiodarone.
    Beckers J; Kulbertus HE
    Eur Heart J; 1987 Mar; 8 Suppl A():53-9. PubMed ID: 3556177
    [No Abstract]   [Full Text] [Related]  

  • 36. Investigation of the antifibrillatory drug interactions between Amiodarone and Ibutilide in isolated, perfused Rabbit hearts.
    Almotrefi AA; Bukhari IA; Alhumayyd MS
    Fundam Clin Pharmacol; 2015 Dec; 29(6):553-7. PubMed ID: 26301534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
    Fujiki A
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):253-60. PubMed ID: 16536075
    [No Abstract]   [Full Text] [Related]  

  • 38. Amiodarone inhibits arrhythmias in hypertensive rats by improving myocardial biomechanical properties.
    Nie Y; He Y; Han D; Liu Y; Li X
    Sci Rep; 2020 Dec; 10(1):21656. PubMed ID: 33303869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appraisal of amiodarone-loaded PLGA nanoparticles for prospective safety and toxicity in a rat model.
    Motawea A; Ahmed DAM; Eladl AS; El-Mansy AAE; Saleh NM
    Life Sci; 2021 Jun; 274():119344. PubMed ID: 33716062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.